Kasai N, Parbtani A, Cameron J S, Yewdall V, Shepherd P, Verroust P
Clin Exp Immunol. 1981 Jan;43(1):64-72.
Immune complex-like material was studied using the platelet-aggregation test (PAT) in 114 patients with idiopathic glomerulonephritis and 55 patients with SLE nephritis, and the results obtained compared with Raji cell and Clq-binding assays. The platelet-aggregating material was not thrombin, and eluted from Sepharose CL/6B columns with a molecular weight of greater than 500,000 daltons. Sera from 17 of 55 patients with SLE nephritis were positive in all three assays, 50/55 in at least one assay. No circulating material was detected by the Raji cell assay in idiopathic glomerulonephritis patients, but both the Clq-binding and PAT assays detected material in patients with acute post-infectious nephritis and mesangiocapillary glomerulonephritis. Patients with membranous nephropathy and Henoch-Schönlein purpura were positive in the PAT, although generally negative in the other assays of immune complexes. The amount of platelet-aggregating material (PAM) found in the sera of patients with both idiopathic glomerulonephritis and SLE nephritis correlated closely with the depletion of intraplatelet serotonin, suggesting that this material is a major mechanism of in vivo platelet activation in these patients.
采用血小板聚集试验(PAT)对114例特发性肾小球肾炎患者和55例系统性红斑狼疮肾炎患者的免疫复合物样物质进行了研究,并将所得结果与拉吉细胞试验和Clq结合试验进行了比较。血小板聚集物质不是凝血酶,从琼脂糖CL/6B柱上洗脱下来时分子量大于500,000道尔顿。55例系统性红斑狼疮肾炎患者中有17例的血清在所有三种试验中均呈阳性,55例中有50例至少在一种试验中呈阳性。在特发性肾小球肾炎患者中,拉吉细胞试验未检测到循环物质,但Clq结合试验和PAT试验在感染后急性肾炎和系膜毛细血管性肾小球肾炎患者中均检测到了物质。膜性肾病和过敏性紫癜患者的PAT试验呈阳性,尽管在其他免疫复合物试验中通常为阴性。在特发性肾小球肾炎和系统性红斑狼疮肾炎患者血清中发现的血小板聚集物质(PAM)的量与血小板内5-羟色胺的消耗密切相关,这表明该物质是这些患者体内血小板活化的主要机制。